This product is not sterile or tested for the presence of endotoxin. Please see the link below to review additional information available in the product datasheet:_x000D_
https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/361/242/t2684dat.pdf
T2684
TiterMax® Gold Adjuvant
liquid
Synonym(s):
TiterMax adjuvant
Sign Into View Organizational & Contract Pricing
Select a Size
1 ML
$320.00
$320.00
Available to ship on10 April 2025Details
All Photos(1)
Select a Size
Change View
1 ML
$320.00
About This Item
$320.00
Available to ship on10 April 2025Details
Recommended Products
General description
TiterMax Gold Adjuvant contains three essential ingredients: a new block copolymer, CRL-8300, squalene (a metabolizable oil) and a sorbitan monooleate.
Application
TiterMax® Gold Adjuvant has been used:
- to emulsify soluble antigen-1 (Ag-1) to immunize animals to generate fully human monoclonal antibodies from XenoMouse strains[1]
- to inject GST-dGIPC (Drosophila homolog of GAIP interacting protein) protein into rats for generating antibodies against dGIPC protein[2]
- with Drosophila CtBP (dCtBP) protein in phosphate-buffered saline (PBS) to subcutaneously inject in a New Zealand female rabbit[1]
Biochem/physiol Actions
Specific proteins can be emulsified with equal volume of TiterMax® Gold Adjuvant to immunize lab animals and extract antibodies from them.[3][4]
TiterMax Gold is a new and improved water-in-oil adjuvant. By developing a new block copolymer and eliminating the silica from the formulation, TiterMax Gold appears to be less toxic and more effective than TiterMax Classic. The optimum volume of TiterMax Gold for an emulsion is twice that of TiterMax Classic.
Legal Information
TiterMax is a registered trademark of TiterMax USA, Inc
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
related product
Product No.
Description
Pricing
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Jihyun Kim et al.
Biochemical and biophysical research communications, 402(3), 565-570 (2010-10-30)
To identify genes that function in the adult neural system, we screened pools of P element-mediated mutants and tested locomotor activity of homozygous flies. Of 1014 P element-mutagenized lines, 638 were homozygous viable. These lines were tested for climbing ability
Fernando Garces et al.
Cell reports, 30(6), 1714-1723 (2020-02-13)
Calcitonin-gene-related peptide (CGRP) plays a key role in migraine pathophysiology. Aimovig (erenumab; erenumab-aooe in the United States) is the only US Food and Drug Administration (FDA)-approved monoclonal antibody (mAb) therapy against the CGRP receptor (CGRPR) for the prevention of migraine.
Anand Srivastava et al.
PloS one, 6(5), e20270-e20270 (2011-06-01)
Var2CSA, a key molecule linked with pregnancy-associated malaria (PAM), causes sequestration of Plasmodium falciparum infected erythrocytes (PEs) in the placenta by adhesion to chondroitin sulfate A (CSA). Var2CSA possesses a 300 kDa extracellular region composed of six Duffy-binding like (DBL)
Paolo Struffi et al.
The Journal of biological chemistry, 280(49), 40757-40765 (2005-09-28)
Knirps and other short range transcriptional repressors play critical roles in patterning the early Drosophila embryo. These repressors are known to bind the C-terminal binding protein corepressor, but their mechanism of action is poorly understood. We purified functional recombinant Knirps
Ning Shen et al.
International journal of molecular sciences, 20(9) (2019-05-15)
Alpha-synuclein is considered the major pathological protein associated with Parkinson's disease, but there is still no effective immunotherapy which targets alpha-synuclein. In order to create a safer and more effective therapy against PD, we are targeting an epitope of alpha-synuclein
-
Is this product sterile? What is the level of endotoxins in this reagent?
1 answer-
Helpful?
-
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
